Purizumubaiorabo
206A.TTSE GROWTHPharmaceutical
Filed as PRISM BioLab Co.,LTD (2024-12–2026-05)
Major holders (5%+) · 5
| Holder | Stake |
|---|---|
| DBJ Capital Co., Ltd. | 15.24% |
| DCI Partners Co., Ltd. | 10.12% |
| Eli Lilly and Company | 7.07% |
| Dai Takehara | 6.08% |
| nakajima kiichiro | 5.29% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 3
| WM PARTNERS Co., Ltd. | 4.88% |
| LifeScience Venture Capital Co., Ltd | 4.29% |
| SBI SECURITIES Co., Ltd. | 0.39% |
Ownership history · 18
| Holder | Ratio | Change |
|---|---|---|
| SBI SECURITIES Co., Ltd.2026-08-06 | 0.39% | -5.11pp |
| SBI SECURITIES Co., Ltd.2026-07-07 | 5.50% | new |
| DBJ Capital Co., Ltd.2025-12-08 | 15.24% | -1.25pp |
| LifeScience Venture Capital Co., Ltd2025-04-01 | 4.29% | -1.01pp |
| LifeScience Venture Capital Co., Ltd2025-01-16 | 5.30% | -1.02pp |
| LifeScience Venture Capital Co., Ltd2024-12-03 | 6.32% | -1.00pp |
| DCI Partners Co., Ltd.2024-10-18 | 10.12% | -1.05pp |
| LifeScience Venture Capital Co., Ltd2024-10-18 | 7.32% | -1.07pp |
| DCI Partners Co., Ltd.2024-10-08 | 11.17% | -1.02pp |
| WM PARTNERS Co., Ltd.2024-07-09 · amended | 4.88% | -1.75pp |
| WM PARTNERS Co., Ltd.2024-07-09 · amended | 6.63% | new |
| LifeScience Venture Capital Co., Ltd.2024-07-09 | 8.39% | new |
| DCI Partners Co., Ltd.2024-07-08 | 12.19% | new |
| DBJ Capital Co., Ltd.2024-07-08 | 16.49% | new |
| Dai Takehara2024-07-08 · amended | 6.08% | -0.09pp |
| Dai Takehara2024-07-08 · amended | 6.17% | new |
| nakajima kiichiro2024-07-05 · amended | 5.29% | new |
| Eli Lilly and Company2024-07-04 | 7.07% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.